83 related articles for article (PubMed ID: 19419786)
1. Paraoxonase-1 activity determination via paraoxon substrate yields no significant difference in mild hyperhomocysteinemia.
Türkeli H; Caycı T; Akgül EÖ; Macit E; Yaman H; Aydın I; Demirin H; Alacam H; Ozkan E; Cakır E; Deren O; Erbil MK; Kunak ZI; Burat K; Akman S
Int J Cardiol; 2010 Nov; 145(1):42-3. PubMed ID: 19419786
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase 1 activity as a predictor of cardiovascular disease in type 2 diabetes.
Poh R; Muniandy S
Southeast Asian J Trop Med Public Health; 2010 Sep; 41(5):1231-46. PubMed ID: 21073045
[TBL] [Abstract][Full Text] [Related]
3. Effect of homocysteinylation on human high-density lipoproteins: a correlation with paraoxonase activity.
Ferretti G; Bacchetti T; Marotti E; Curatola G
Metabolism; 2003 Feb; 52(2):146-51. PubMed ID: 12601623
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease.
Kerkeni M; Letaief A; Achour A; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2009 Jun; 42(9):777-82. PubMed ID: 19233152
[TBL] [Abstract][Full Text] [Related]
6. Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes.
Weijun G; Juming L; Guoqing Y; Jingtao D; Qinghua G; Yiming M; Changyu P
Adv Ther; 2008 Sep; 25(9):884-93. PubMed ID: 18781288
[TBL] [Abstract][Full Text] [Related]
7. Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice.
Noll C; Hamelet J; Matulewicz E; Paul JL; Delabar JM; Janel N
J Nutr Biochem; 2009 Aug; 20(8):586-96. PubMed ID: 18676137
[TBL] [Abstract][Full Text] [Related]
8. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Jakubowski H
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia induces hepatic cholesterol biosynthesis and lipid accumulation via activation of transcription factors.
Woo CW; Siow YL; Pierce GN; Choy PC; Minuk GY; Mymin D; O K
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E1002-10. PubMed ID: 15644462
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of a HPLC method for simultaneous quantitation of plasma homocysteine and cysteine.
Atamasirikul K; Kajanachumpol S; Wilairat P; Tantibhedhyangkul P
J Med Assoc Thai; 2008 Mar; 91(3):338-44. PubMed ID: 18575286
[TBL] [Abstract][Full Text] [Related]
12. Associations between serum insulin and homocysteine in a Swedish population-a potential link between the metabolic syndrome and hyperhomocysteinemia: the Skaraborg project.
Björck J; Hellgren M; Råstam L; Lindblad U
Metabolism; 2006 Aug; 55(8):1007-13. PubMed ID: 16839834
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation inhibits NADPH oxidase-mediated superoxide anion production in the kidney.
Hwang SY; Siow YL; Au-Yeung KK; House J; O K
Am J Physiol Renal Physiol; 2011 Jan; 300(1):F189-98. PubMed ID: 20980407
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
Agachan B; Yilmaz H; Karaali Z; Isbir T
Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of hyperhomocysteinemia in dialysis patients].
Lovcić V; Kes P; Reiner Z
Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
[TBL] [Abstract][Full Text] [Related]
16. Serum folate is a reliable indicator of hyperhomocysteinemia and borderline hyperhomocysteinemia in young adults.
Cheng CH; Tsai TP; Chen WS; Huang YC
Nutr Res; 2009 Oct; 29(10):743-9. PubMed ID: 19917455
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase polymorphism in northwestern Indians.
Singh S; Verma M; Nain CK; Co L; Goel RC; Sharma BK
Int J Clin Pharmacol Ther; 1998 Oct; 36(10):545-8. PubMed ID: 9799059
[TBL] [Abstract][Full Text] [Related]
18. The antiatherogenic function of HDL is impaired in hyperhomocysteinemic subjects.
Holven KB; Aukrust P; Retterstøl K; Otterdal K; Bjerkeli V; Ose L; Nenseter MS; Halvorsen B
J Nutr; 2008 Nov; 138(11):2070-5. PubMed ID: 18936200
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocysteinemia in patients with stasis dermatitis and ulcer: a novel finding with important therapeutic implications.
Durmazlar SP; Akgul A; Eskioglu F
J Dermatolog Treat; 2009; 20(6):336-9. PubMed ID: 19954389
[TBL] [Abstract][Full Text] [Related]
20. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
Speidl WS; Nikfardjam M; Niessner A; Zeiner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
Thromb Res; 2007; 119(3):331-6. PubMed ID: 16616324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
